{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:58:54Z","timestamp":1788872334995,"version":"build-2803163510"},"reference-count":32,"publisher":"Georg Thieme Verlag KG","issue":"07","funder":[{"name":"Assistance publique-Hopitaux de Marseille"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2012]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Optimal platelet reactivity (PR) inhibition is critical to prevent thrombotic events in primary percutaneous coronary intervention (PCI). We aimed to determine the relationship between high on-treatment platelet reactivity (HTPR) and ST-elevation myocardial infarction (STEMI) following a 600 mg loading dose (LD) of clopidogrel. We performed a prospective monocentre study enrolling patients on clopidogrel undergoing PCI. The VASP index was used to assess PR inhibition after clopidogrel LD. HTPR was defined according to the consensus as a VASP index \u226550%. The present study included 833 patients undergoing PCI. Most patients had PCI for an acute coronary syndrome (58.7%). The mean VASP index was 50 \u00b1 23% with a large inter-individual variability (range: 1\u201394%). Patients with a VASP index \u226550% were significantly older (p= 0.03), with a higher body mass index (BMI) (p&lt;0.001), more often diabetic (p=0.03), taking omeprazole (p=0.03), admitted for an acute coronary syndrome (ACS) and with a high fibrinogen level compared to good responders (VASP &lt;50%). In multivariate analysis BMI, omeprazole use, ACS and high fibrinogen level (p&lt;0.001) remained significantly associated with HTPR. Of importance, in this analysis STEMI was independently associated with HTPR when compared with the other forms of ACS (NSTEMI and unstable angina) with an odd ratio of 2.14 (95% CI: 1.3 \u20133.5; p=0.003). In conclusion, STEMI is associated with high on-treatment platelet reactivity following 600 mg of clopidogrel. The present results suggest that 600 mg of clopidogrel may not be able to achieve an optimal PR inhibition in STEMI patients undergoing PCI and more potent drugs may be preferred.<\/jats:p>","DOI":"10.1160\/th12-02-0125","type":"journal-article","created":{"date-parts":[[2012,4,26]],"date-time":"2012-04-26T07:46:59Z","timestamp":1335426419000},"page":"101-106","source":"Crossref","is-referenced-by-count":22,"title":["Biological efficacy of a 600 mg loading dose of clopidogrel in ST-elevation myocardial infarction"],"prefix":"10.1160","volume":"108","author":[{"given":"Julie","family":"Berbis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Laine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Armero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Bessereau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Jacquin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bonello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Camillieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Barragan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Dignat-George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Paganelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Camoin-Jau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"10.1160\/TH12-02-0125-1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604253341702"},{"key":"10.1160\/TH12-02-0125-2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000160869.75810.98"},{"key":"10.1160\/TH12-02-0125-3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.04.047"},{"key":"10.1160\/TH12-02-0125-4","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.10497"},{"key":"10.1160\/TH12-02-0125-5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02609.x"},{"key":"10.1160\/TH12-02-0125-6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03733.x"},{"key":"10.1160\/TH12-02-0125-7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.051"},{"key":"10.1160\/TH12-02-0125-8","doi-asserted-by":"crossref","unstructured":"Sibbing D, von Beckerath O, Sch\u00f6mig A , et al. Platelet function in clopidogrel-treated patients with acute coronary syndrome. Blood Coagul Fibrinolysis. 2007; 18: 335-9. TRITON-TIMI 38 Investigators.Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007; 357: 2001-2015.","DOI":"10.1056\/NEJMoa0706482"},{"key":"10.1160\/TH12-02-0125-9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60441-4"},{"key":"10.1160\/TH12-02-0125-10","doi-asserted-by":"crossref","unstructured":"Van de Werf F, Bax J, Betriu A, et al.; ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-2945.","DOI":"10.1093\/eurheartj\/ehn416"},{"key":"10.1160\/TH12-02-0125-11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm132"},{"key":"10.1160\/TH12-02-0125-12","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.10494"},{"key":"10.1160\/TH12-02-0125-13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.08.006"},{"key":"10.1160\/TH12-02-0125-14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.07.004"},{"key":"10.1160\/TH12-02-0125-15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.08.048"},{"key":"10.1160\/TH12-02-0125-16","doi-asserted-by":"publisher","DOI":"10.1002\/clc.20884"},{"key":"10.1160\/TH12-02-0125-17","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-03-0202"},{"key":"10.1160\/TH12-02-0125-18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.06.004"},{"key":"10.1160\/TH12-02-0125-19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02598.x"},{"key":"10.1160\/TH12-02-0125-20","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.22248"},{"key":"10.1160\/TH12-02-0125-21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.05.031"},{"key":"10.1160\/TH12-02-0125-22","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2008.01.021"},{"key":"10.1160\/TH12-02-0125-23","first-page":"169","volume":"16","author":"Angiolillo","year":"2004","journal-title":"J Invasive Cardiol"},{"key":"10.1160\/TH12-02-0125-24","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.07.015"},{"key":"10.1160\/TH12-02-0125-25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.064"},{"key":"10.1160\/TH12-02-0125-26","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.8.2430"},{"key":"10.1160\/TH12-02-0125-27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00836.x"},{"key":"10.1160\/TH12-02-0125-28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.07.068"},{"key":"10.1160\/TH12-02-0125-29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03599.x"},{"key":"10.1160\/TH12-02-0125-30","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-05-0266"},{"key":"10.1160\/TH12-02-0125-31","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-011-0286-4"},{"key":"10.1160\/TH12-02-0125-32","doi-asserted-by":"publisher","DOI":"10.1038\/nri2171"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1160\/TH12-02-0125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T20:05:57Z","timestamp":1561665957000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1160\/TH12-02-0125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":32,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2017,11,22]]},"published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1160\/th12-02-0125","relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}